956017-49-5

Upstream product

• 1099821-38-1 5-[3-((1R,2S,3R,5R)-3-(tert-butyl-dimethyl-silanyloxy)-5-chloro-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 

Downstream Products

• 956017-50-8 5-[3-((1S,5S)-5-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-4-oxo-cyclopent-2-enyl)-propyl]-thiophene-2-carboxylic acid methyl ester 
• 956017-55-3 5-[3-((1S,2S)-3,3-Dichloro-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 
• 956017-51-9 5-[3-((1S,2S)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-oxo-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J, B, Y, and A are as described in claims 1-13. Methods, compositions, and medicaments related thereto are also disclosed, for treating baldness, glauco

THERAPEUTIC COMPOUNDS

A compound having a structure is disclosed herein. Compositions, medicaments, and therapeutic methods related thereto are also disclosed.